by According to Precedence Research, during the forecast period of 2020 to 2027, the global mHealth apps market is estimated to develop at a compound annual growth rate (CAGR) of 43.9%. and it is predicted to exceed USD 240.65 billion by 2027. The study investigates several elements and their consequences on the growth of the mHealth apps market.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1061
Growth Factor
Augmented expenditure by the healthcare participants and escalating emphasis on ailment management and precautionary care has stimulated the active participation of healthcare consultants and patients across the medical care and hospitals. The extraordinary growth of mobile technologies as well as advancements in their innovative application concerning health priorities have evolved across the globe, which has resulted in creating numerous opportunities in the field of eHealth. In addition to this, the health consciousness across the global population has been drastically increased, creating extensive demand for e-Health services. In the recent years, the traditional health service provider-centric modules have been replaced by patient-centric care modules, complementary to this, the use of mHealth applications has reduced the time required and increased the smoothness in ongoing healthcare operations.
Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1061
This report focuses on mHealth apps market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall mHealth apps market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Report Highlights
- Presently, due to unhealthier lifestyles across the global population prevalence of chronic diseases has increased the demand for mHealth applications.
- Increasing assistance from global healthcare organizations likes WHO and government support has created a favorable environment for the mHealth application market development.
- Healthcare service providers and Physicians are increasingly recommending the use of mHealth applications resulted in upsurges adoption rates and the number of users.
- North American mHealth apps market has dominated in the years 2020 with respect to comparatively strengthening technological and healthcare infrastructure.
- The COVID19 pandemic has drastically affected the mHealth apps market dynamics to a significant extent. Since the majority of the market and leading countries are drastically impacted by the ongoing pandemic.
In-Depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of mHealth apps, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of mHealth apps has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the mHealth apps market.
Some of the prominent players in the mHealth apps market include:
- Abbott Laboratories
- Johnson and Johnson
- AstraZeneca PLC
- Hoffmann-La Roche Ltd.
- Novartis AG
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc
- Merck and Co., Inc.
- Pfizer, Inc.
- iHealth Labs Inc.
- Vivify Health
- Medtronic MiniMed, Inc.
Segments Covered in the Report
By Type
- Nutrition & Diet
- Women’s Health
- Medication Adherence
- Fitness
- Lifestyle Management
- Healthcare Providers/Payers
- Disease Management
- Others
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- What value propositions should businesses aim at while making new research and development funding?
- Which regulations will be most helpful for stakeholders to boost their supply chain network?
- Which regions might see the demand maturing in certain segments in near future?
- What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
- Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
- Which government regulations might challenge the status of key regional markets?
- How will the emerging political and economic scenario affect opportunities in key growth areas?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global mHealth Apps Market, By Type
7.1. mHealth Apps Market, by Type, 2020-2027
7.1.1. Nutrition & Diet
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Women’s Health
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Medication Adherence
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Fitness
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Lifestyle Management
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Healthcare Providers/Payers
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Disease Management
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Others
7.1.8.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global mHealth Apps Market, Regional Estimates and Trend Forecast
8.1. North America
8.1.1. Market Revenue and Forecast, by Type (2016-2027)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, by Type (2016-2027)
8.2. Europe
8.2.1. Market Revenue and Forecast, by Type (2016-2027)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, by Type (2016-2027)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, by Type (2016-2027)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, by Type (2016-2027)
8.3. APAC
8.3.1. Market Revenue and Forecast, by Type (2016-2027)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, by Type (2016-2027)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, by Type (2016-2027)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, by Type (2016-2027)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, by Type (2016-2027)
8.4. MEA
8.4.1. Market Revenue and Forecast, by Type (2016-2027)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, by Type (2016-2027)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, by Type (2016-2027)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, by Type (2016-2027)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, by Type (2016-2027)
8.5. Latin America
8.5.1. Market Revenue and Forecast, by Type (2016-2027)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, by Type (2016-2027)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, by Type (2016-2027)
Chapter 9. Company Profiles
9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Johnson and Johnson
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. AstraZeneca PLC
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Hoffmann-La Roche Ltd.
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Novartis AG
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Bristol-Myers Squibb Company
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. GlaxoSmithKline plc
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. Merck and Co., Inc.
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
9.9. Pfizer, Inc.
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives
9.10. iHealth Labs Inc.
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives
9.11. Vivify Health
9.11.1. Company Overview
9.11.2. Product Offerings
9.11.3. Financial Performance
9.11.4. Recent Initiatives
9.12. Medtronic MiniMed, Inc.
9.12.1. Company Overview
9.12.2. Product Offerings
9.12.3. Financial Performance
9.12.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1061
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
